PROFUND ADVISORS LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in DYN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,306,170

-$182,991 QoQ

Shares Held

58,810

-28.4% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#111

of 245 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. DYN ranks #50 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,306,170	58,810	-28.4%	Shares	Sole	2026-08-11
2026-03-31	$1,489,161	82,138	-5.3%	Shares	Sole	2026-04-27
2025-12-31	$1,696,751	86,746	+88.7%	Shares	Sole	2026-02-06
2025-09-30	$581,647	45,980	+94.5%	Shares	Sole	2025-11-06
2025-06-30	$225,071	23,642	-23.0%	Shares	Sole	2025-08-07
2025-03-31	$321,320	30,719	-5.8%	Shares	Sole	2025-05-08
2024-12-31	$767,914	32,594	-0.9%	Shares	Sole	2025-02-14
2024-09-30	$1,181,480	32,892	+20.0%	Shares	Sole	2024-11-14
2024-06-30	$967,687	27,421	-48.7%	Shares	Sole	2024-08-13
2024-03-31	$1,517,360	53,447	+98.2%	Shares	Sole	2024-05-08
2023-12-31	$358,594	26,962	+13.3%	Shares	Sole	2024-02-14
2023-09-30	$213,185	23,793	+9.8%	Shares	Sole	2023-11-13
2023-06-30	$243,697	21,662	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.